Cannabidiol Industry Analysis, By Source (Hemp-based CBD, Marijuana-based CBD), By Form (CBD Processed Oil, CBD Distillate, CBD Isolate), By Grade (Food Grade CBD, Therapeutic Grade CBD), By Application (Food & Beverage, Cosmetics & Personal Care, Pharmaceuticals) - Global Market Review 2021 to 2031
According to a new analysis by Fact.MR, the global cannabidiol (CBD) market will hit US$ 3 Bn by 2021. The market for cannabidiol products further expand to surpass US$ 34 Bn by 2031, expanding more than 11x, thanks to rising demand for full legalization and a ready consumer base.
Key Points Addressed in CBD Industry Analysis
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on CBD and How to Navigate
- Recommendation on Key Winning Strategies
Know More Details About the Report
Consumption Analysis of CBD from 2016-2020 Vs Future Outlook 2021-2031
The global market for CBD was worth US$ 2.9 Bn in 2020, expanding at an impressive CAGR. The demand for cannabidiol (CBD) for health and wellness purposes is strong due to its therapeutic characteristics, which is a major factor driving market growth.
Furthermore, increased product acceptance and use as a result of regulatory approvals are likely to promote CBD-infused product production.
A growing understanding of CBD's therapeutic potential has inspired a buyer to purchase cannabidiol products regardless of price. Commercial merchants are now focusing on marketing cannabis-based items since they offer a higher profit margin.
According to Fact.MR- a market research and competitive intelligence provider- the market is predicted to increase nearly 28% CAGR from 2021 to 2031.
How is Alleviation of Restrictions Fueling CBD Products Demand?
Cannabis comprises over 100 chemical compounds known as cannabinoids, with the most common among them being CBD and THC. The World Health Organization’s Expert Committee on Drug Dependence (ECDD) published a report in 2017, which acknowledges clinical employment of CBD to be the most advanced treatment of epilepsy.
CBD is perceived to have significant therapeutic value for seizures on account of epilepsy and relevant conditions. In addition, clinical trials conducted on CBD have depicted its efficacy in treatment of various forms of epilepsy. Based on this development, countries are seeking to incorporate CBD-based therapeutics which will significantly generate demand.
Avail customized purchase options for your needs
Increasing Application of Marijuana-based CBD Products Fueling Expansion?
By 2028, marijuana based cannabidiol industry is expected to be worth US$ 31 Bn. CBD is derived as an oil or a powder from marijuana plants. These can be blended into lotions or gels, or put into capsules and ingested or applied to the skin.
Tetrahydrocannabinol (THC) is also used in the creation of medications to treat neurological illnesses like dementia, Alzheimer's disease, epilepsy, and other conditions. Because of its psychotropic characteristics, THC is heavily restricted in the majority of countries; as a result, it is expected to grow slowly in comparison to hemp.
Side-effects associated with CBD Products to Impede Adoption?
Cannabidiol is well-known for its ability to cure a variety of illnesses, including anxiety, seizures, neurological problems, cancer-related nausea, chronic pain, and more. Despite being useful for a variety of medical illnesses, studies and research conducted by numerous organizations have shown that CBD-based medicines can nevertheless have minor negative effects.
Dry mouth, drowsiness, low blood pressure, and lightheadedness are just a few of the negative effects experienced by consumers. CBD is also known to raise the level of coumadin (a blood thinner) in the body, which can interact with other drugs and cause negative side effects. These factors might impede future adoption of CBD for therapeutic purposes.
An Adaptive Approach to Modern-day Research Needs
What Supports Increasing CBD Sales in U.S.?
Over the last few years, North America appears to possess the highest income potential in the cannabis pharmaceutical sector. Favorable restrictions in some locations, most notably in the U.S, are limiting the surge of interest in medical marijuana.
The regional market's potential will be cemented by intense discussion among industry stakeholders concerning the taxation and labeling of cannabis-based therapeutic items. According to Fact.MR, nearly 40% of CBD demand in North America will be generated by the U.S.
How is Asia Emerging as an Important CBD Stakeholder?
Due to the cultivation of hemp-producing plants, particularly in China, the market in Asia is expected to develop at the quickest rate over the forecast period.
China is Asia's greatest hemp producer, generating roughly half of all hemp worldwide. Around 89% of the country's products are exported to the United States, Germany, the United Kingdom, the Netherlands, and Japan, and hemp cultivation for cannabidiol extraction has begun in three regions.
Category wise Insights
Why is CBD Processed Oil Highly Preferred?
Anxiety and depression treatment, stress reduction, diabetes prevention, pain relief, cancer symptom relief, and inflammation are all uses for cannabidiol oil.
The global cannabidiol market is expected to develop at a lucrative rate over the forecast period, owing to the increased acceptance of CBD-based products to treat diseases. A CAGR of 8% is projected for this segment.
Why is CBD Uptake High across Pharmaceutical Industries?
Medical marijuana and cannabis-based medications have opened up new options in the pharmaceutical sector. Small and large pharmaceutical businesses have poured money into cannabidiol (CBD) research.
CBD and CBD-based products have made a significant inroad, riding the tide of marijuana legalization in stages. The segment dominated the CBD market in 2020, capturing nearly 43% revenue.
Have a report related query? Speak to us directly
In the following decade, manufacturers in the Cannabidiol industry will focus on strategic acquisitions, collaborations, and new launches.
- Greenheart CBD, an Irish company, became the first CBD manufacturer to launch a decentralized financial token in March 2021. The token will aid the company's expansion and provide token holders with cost-effective products.
- With a new CBD nutraceutical to be packaged by ALKM and marketed by USMJ, PAOG hopes to tap into an US$ 18 billion market opportunity. PAOG is on pace to introduce a CBD Nutraceuticals range of products that will generate income this year, in 2021.
Historical Data Available for
|US$ Mn for Value & ‘000 Units for Volume|
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered
- Hemp-based CBD
- Marijuana-based CBD
- CBD Processed Oil
- CBD Distillate
- CBD Isolate
- Food Grade CBD
- Therapeutic Grade CBD
- CBD for Food & Beverage
- CBD for Cosmetics & Personal Care
- CBD for Pharmaceuticals
- CBD for Other Applications
Cannabidiol (CBD) Market- Scope of Report
A recent study by Fact.MR on the cannabidiol (CBD) market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering cannabidiol.
The study also provides the dynamics responsible for influencing the future status of the CBD market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the CBD market, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of CBD across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of CBD during the forecast period. Price point comparison by region with global average price is also considered in the study.
Fact.MR has studied the CBD market with detailed segmentation on the basis of source, form, grade, application and region.
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Key Questions Answered in Report
- Which are the most lucrative CBD markets?
- Which factors will impact the growth of CBD?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the CBD industry?
- What are the winning strategies of stakeholders in the market?
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).
Estimates at global and regional levels for CBD are available in terms of “US$ Mn” for value and in ‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global CBD market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the CBD during the forecast period.
Country-specific valuation on demand for CBD has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Analysis on Competition Analysis
The report sheds light on leading manufacturers of CBD, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering CBD has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the CBD domain. Prominent companies operating in this space include INSYS Therapeutics, Inc., EPIDIOLEX, Nightfood Holdings, SolMic GmbH, Pivot Pharmaceuticals Inc., Marijuana Company of America Inc., HoneyB Healthy and Nightfood Holdings among others.
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the CBD industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQs -
As of 2021, the global market for CBD will be valued at US$ 3 Bn as per a recent Fact.MR study
From 2016 to 2020, the CBD industry surged at an impressive rate, reaching US$ 2.9 Bn by the end of the said period
According to Fact.MR, future CBD sales are expected to reach US$ 34 Bn by 2031
The global market for CBD is touted to expand at a whopping 28% CAGR from 2021-2031
Increasing scramble to legalize commercial CBD usage for various purposes is likely to drive market growth in forthcoming years
The U.S is anticipated to account for nearly 40% of CBD demand across North America
Asia is anticipated to be highly attractive, with China pivoting bulk of all growth
Pharmaceuticals are expected to account for over 2/5th of the global CBD industry sales
CBD processed oil is highly preferred, expected to surge at around 8% CAGR until 2031
Hemp-based CBD accounted for nearly 60% of the revenue in 2020
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.